-Bloomberg
Related Posts
Pros Holdings Earnings Perspective: Return On Capital Employed
According to data from Benzinga Pro, during Q2, Pros Holdings's (NYSE:PRO) reported sales totaled $68.36 million. Despite a 21.77% increase in earnings, the company posted a loss of $22.41 million.
Eiger Bio’s Avexitide Reduces Glucose Infusion Requirements To Maintain Normal Glucose Levels In Neonates, Infants
Eiger BioPharmaceuticals Inc (NASDAQ: EIGR) announced an oral poster presentation of Phase 2 study results of Avexitide in congenital hyperinsulinism (HI) at the American Diabetes Association Scientific Session.
UBS Initiates Coverage On argenx with Buy Rating, Announces Price Target of $390
UBS analyst Laura Sutcliffe initiates coverage on argenx (NASDAQ:ARGX) with a Buy rating and announces Price Target of $390.